Comparative analysis of persistence and remission with guselkumab versus secukinumab and ixekizumab in the United States

• Main Authors: Maryia Zhdanava (Author), Timothy Fitzgerald (Author), Dominic Pilon (Author), Rachel E. Teneralli (Author), Aditi Shah (Author), Lilian Diaz (Author), Patrick Lefebvre (Author), Steven R. Feldman (Author)
• Format: Book
• Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

AbstractPurpose: Real-world data comparing long-term performance of interleukin (IL)-23 and IL-17 inhibitors in psoriasis are limited. This study compared treatment persistence and remission among patients initiating guselkumab versus IL-17 inhibitors.Methods: Adults with psoriasis initiating guselk...